封面
市場調查報告書
商品編碼
1535746

阿拉伯木聚醣纖維市場規模- 按應用(藥品、飲料、食品、動物營養[[寵物、家禽、反芻動物、豬]])、按來源(大麥、米、玉米、燕麥、小麥)和預測,2024 - 2032 年

Arabinoxylan Fiber Market Size - By Application (Pharmaceutical, Beverages, Food, Animal Nutrition [[Pet, Poultry, Ruminants, Swine]]), By Source (Barley, Rice, Maize, Oats, Wheat) & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於食品中天然和植物組成的趨勢不斷成長,2024年至2032年全球阿拉伯木聚醣纖維市場的複合年成長率將超過8.5%。

消費者越來越意識到天然纖維對健康的益處,包括它們在增強消化健康和支持健康方面的作用。隨著越來越多的人尋求更健康和永續的食物選擇,對阿拉伯木聚醣纖維的需求不斷增加。更廣泛的清潔標籤和最低限度加工食品運動正在鼓勵餐飲企業投資研發並引入新原料,進一步推動市場成長。例如,2024 年 2 月,Ingredion 推出了 NOVATION(R) Indulge 2940,這是一種清潔標籤、非基因改造澱粉,可增強乳製品和植物性產品的膠凝和口感。這項創新提供了一種以玉米為基礎的天然替代品,滿足了注重健康的消費者對口感的需求。

整個阿拉伯木聚醣纖維市場根據應用、來源和地區進行分類。

由於其固有的功能優勢和增強的營養成分,小麥細分市場從 2024 年到 2032 年將出現顯著的複合年成長率。隨著消費者和製造商優先考慮全穀物和富含纖維的食品,添加阿拉伯木聚醣的小麥產品可改善健康特性,例如更好的消化健康和血糖控制。有利於高纖維飲食的營養趨勢導致對小麥阿拉伯木聚醣纖維的需求不斷成長。

在阿拉伯木聚醣纖維的潛在治療應用和健康益處的推動下,到 2032 年,藥品領域將佔據顯著的市場佔有率。隨著製藥公司探索藥物配方的天然和植物成分,該產品在增強藥物傳輸系統和提高生物利用度方面的作用變得非常重要。它用於開發膳食補充劑和功能性食品,提供免疫支持和腸道健康等健康益處。在藥品中加入更多天然成分的轉變符合消費者對整體健康解決方案的偏好,該領域的需求不斷成長。

由於人們越來越關注健康和保健趨勢,歐洲阿拉伯木聚醣纖維市場從 2024 年到 2032 年將呈現強勁的複合年成長率。歐洲消費者正在尋求天然和永續的飲食解決方案,並偏好具有健康益處且源自可再生資源的纖維。對在食品和補充劑中加入有益纖維的監管支持鼓勵採用阿拉伯木聚醣纖維。再加上消費者對此產品作用的認知不斷提高,將有利於歐洲市場的成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
    • 主要製造商
    • 經銷商
    • 全行業利潤率
  • 產業影響力
    • 成長動力
      • 由於貿易情勢積極,原料供應成本低廉
      • 增加烘焙應用中的產品使用量
      • 膳食纖維市場快速擴張,國慶慶典更受到關注
    • 市場挑戰
      • 過量膳食纖維的有害影響以及多樣化的藥品法規
    • 市場機會
      • 新機遇
      • 成長潛力分析
  • 原料景觀
    • 製造趨勢
    • 技術演進
      • 永續製造
        • 綠色實踐
        • 脫碳
    • 原料的永續性
    • 價格趨勢(美元/噸)
  • 法規和市場影響
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場規模與預測:按來源分類,2021-2032 年

  • 主要趨勢
  • 小麥
  • 大麥
  • 燕麥
  • 玉米
  • 其他

第 6 章:市場規模與預測:按應用分類,2021-2032 年

  • 主要趨勢
  • 食物
    • 麵包店
    • 早餐麥片和零食
    • 糖果點心
    • 乳製品
    • 肉製品
    • 嬰兒食品
  • 飲料
  • 製藥
  • 動物營養
    • 反芻動物
    • 家禽
    • 寵物
  • 其他(個人護理和化妝品)

第 7 章:市場規模與預測:按地區分類,2021-2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • MEA
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • MEA 的其餘部分

第 8 章:公司簡介

  • Shandong Zhi Shang Chemical Co. Ltd
  • Nanjing Raymon Biotech Co., Ltd
  • Acetar Bio-tech Inc
  • Triumph International Development Limited
  • Daiwa Pharmaceutical
  • Megazyme
  • Antimex Pharmaceuticals & Chemicals Ltd
  • Comet Biorefining
  • Cargill
  • Kowa India Pvt. Ltd
  • J. Rettenmaier & Sohne GmbH & Co. K
  • HL Agro
  • BioActor BV
簡介目錄
Product Code: 4656

Global Arabinoxylan Fiber Market will record over 8.5% CAGR from 2024 to 2032, owing to the growing trend towards natural and plant-based ingredients in food products.

There is an increase in consumer awareness of the health benefits associated with natural fibers, including their role in enhancing digestive health and supporting wellness. As more individuals seek healthier and sustainable food options, the demand for arabinoxylan fiber escalates. The broader movement towards clean labels and minimally processed foods is encouraging the F&B players to invest in R&D and introduce new ingredients, further propelling the market growth. For instance, in February 2024, Ingredion launched NOVATION(R) Indulge 2940, a clean-label, non-GMO starch enhancing gelling and mouthfeel in dairy and plant-based products. This innovation offers a natural, corn-based alternative, meeting the demands of health-conscious consumers for indulgent textures.

The overall arabinoxylan fiber market is sorted based on application, source, and region.

The wheat segment will witness a noteworthy CAGR from 2024 to 2032, due to its inherent functional benefits and enhanced nutritional profile. As consumers and manufacturers prioritize whole grain and fiber-rich foods, wheat products fortified with arabinoxylan offer improved health attributes, such as better digestive health and glycemic control. The nutritional trends favoring high-fiber diets contribute to the rising demand for wheat-based arabinoxylan fiber.

The pharmaceuticals segment will capture a notable market share by 2032, driven by the potential therapeutic applications and health benefits of arabinoxylan fiber. As pharmaceutical companies explore natural and plant-based ingredients for drug formulations, the product's role in enhancing drug delivery systems and improving bioavailability becomes significant. It is used in developing dietary supplements and functional foods, offering health benefits such as immune support and gut health. The shift towards incorporating more natural components in pharmaceutical products aligns with consumer preferences for holistic health solutions, thriving demand in the segment.

Europe arabinoxylan fiber market will demonstrate a strong CAGR from 2024 to 2032, owing to a growing focus on health and wellness trends. Consumers in Europe are seeking natural and sustainable dietary solutions, aligning with a preference for fibers that offer health benefits and are derived from renewable sources. The regulatory support for incorporating beneficial fibers in food and supplements is encouraging the adoption of arabinoxylan fiber. This, combined with heightened consumer awareness of the product's role, will favor the market growth in Europe.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Key manufacturers
    • 3.1.2 Distributors
    • 3.1.3 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Low cost raw material availability due to positive trade scenario
      • 3.2.1.2 Increasing product usage in bakery application
      • 3.2.1.3 Rapid expansion in dietary fibers market along with enhanced focus on NDP
    • 3.2.2 Market challenges
      • 3.2.2.1 Harmful effect of excessive dietary fiber along with diverse pharmaceutical regulations
    • 3.2.3 Market opportunity
      • 3.2.3.1 New opportunities
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
    • 3.3.2 Technology evolution
      • 3.3.2.1 Sustainable manufacturing
        • 3.3.2.1.1 Green practices
        • 3.3.2.1.2 Decarbonization
    • 3.3.3 Sustainability in raw materials
    • 3.3.4 Pricing trends (USD/Ton)
      • 3.3.4.1 North America
      • 3.3.4.2 Europe
      • 3.3.4.3 Asia Pacific
      • 3.3.4.4 Latin America
      • 3.3.4.5 Middle East & Africa
  • 3.4 Regulations & market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Tons)

  • 6.1 Key trends
  • 6.2 Wheat
  • 6.3 Rice
  • 6.4 Barley
  • 6.5 Oats
  • 6.6 Maize
  • 6.7 Others

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

  • 5.1 Key trends
  • 5.2 Food
    • 5.2.1 Bakery
    • 5.2.2 Breakfast cereals & snacks
    • 5.2.3 Confectionery
    • 5.2.4 Dairy
    • 5.2.5 Meat products
    • 5.2.6 Infant food
  • 5.3 Beverages
  • 5.4 Pharmaceutical
  • 5.5 Animal nutrition
    • 5.5.1 Swine
    • 5.5.2 Ruminants
    • 5.5.3 Poultry
    • 5.5.4 Pet
  • 5.6 Others (personal care & cosmetics)

Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 MEA
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 South Africa
    • 7.6.4 Rest of MEA

Chapter 8 Company Profiles

  • 8.1 Shandong Zhi Shang Chemical Co. Ltd
  • 8.2 Nanjing Raymon Biotech Co., Ltd
  • 8.3 Acetar Bio-tech Inc
  • 8.4 Triumph International Development Limited
  • 8.5 Daiwa Pharmaceutical
  • 8.6 Megazyme
  • 8.7 Antimex Pharmaceuticals & Chemicals Ltd
  • 8.8 Comet Biorefining
  • 8.9 Cargill
  • 8.10 Kowa India Pvt. Ltd
  • 8.11 J. Rettenmaier & Sohne GmbH & Co. K
  • 8.12 HL Agro
  • 8.13 BioActor BV